Co-Diagnostics, Inc. SEC filings CODX
Co-Diagnostics, Inc. has 390 filings in SEC EDGAR's recent list, going back to Dec 29, 2016. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3 | Shelf registration | Nov 4, 2026 | — |
| DEF 14A | Proxy statement | Oct 26, 2026 | Oct 26, 2026 |
| PRE 14A | Preliminary proxy statement | Oct 16, 2026 | Oct 16, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Oct 15, 2026 | Oct 14, 2026 |
| 8-K/A |
Amended current report
Material agreement, New debt, Unregistered share sale
|
Oct 15, 2026 | Oct 9, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Oct 13, 2026 | Oct 9, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Oct 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Sep 25, 2026 | Sep 3, 2026 |
| PRE 14A | Preliminary proxy statement | Sep 21, 2026 | Sep 21, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 16, 2026 | Sep 16, 2026 |
| 8-K |
Current report
Other events
|
Sep 16, 2026 | Sep 16, 2026 |
| 8-K |
Current report
Other events
|
Sep 15, 2026 | Aug 25, 2026 |
| 3 | Initial insider ownership | Sep 14, 2026 | Sep 2, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 4, 2026 | Sep 2, 2026 |
| DEFA14A | Additional proxy material | Sep 4, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
Sep 4, 2026 | Sep 3, 2026 |
| EFFECT | Filing | Sep 1, 2026 | — |
| S-3 | Shelf registration | Aug 24, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 13, 2026 | Aug 13, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 10, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jul 31, 2026 | Jul 30, 2026 |
| 8-K |
Current report
Material agreement
|
Jul 27, 2026 | Jul 27, 2026 |
| 424B5 | Prospectus supplement | Jul 27, 2026 | — |
| DEF 14A | Proxy statement | Jul 21, 2026 | Jul 21, 2026 |
| PRE 14A | Preliminary proxy statement | Jul 10, 2026 | Jul 9, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 3, 2026 | — |
| EFFECT | Filing | May 29, 2026 | — |
| CORRESP | Letter to the SEC | May 28, 2026 | — |
| S-3 | Shelf registration | May 28, 2026 | — |
| UPLOAD | Letter from the SEC | May 28, 2026 | — |
| 4 | Insider transaction | May 27, 2026 | May 23, 2026 |
| 4 | Insider transaction | May 27, 2026 | May 23, 2026 |
| 4 | Insider transaction | May 27, 2026 | May 23, 2026 |
| 4 | Insider transaction | May 27, 2026 | May 23, 2026 |
| 4 | Insider transaction | May 27, 2026 | May 23, 2026 |
| 4 | Insider transaction | May 27, 2026 | May 27, 2026 |
| 4 | Insider transaction | May 27, 2026 | May 23, 2026 |
| DRS | Filing | May 22, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
May 21, 2026 | May 19, 2026 |
| EFFECT | Filing | May 15, 2026 | — |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 14, 2026 | May 14, 2026 |
| CORRESP | Letter to the SEC | May 13, 2026 | — |
| S-3 | Shelf registration | May 12, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 14, 2026 | — |
| DRS | Filing | Apr 10, 2026 | — |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 31, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
Mar 10, 2026 | Mar 9, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 11, 2026 | — |
| S-8 | Employee stock plan registration | Jan 21, 2026 | — |
| 8-K |
Current report
Listing notice
|
Jan 13, 2026 | Jan 7, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Dec 30, 2025 | Dec 29, 2025 |
| 424B5 | Prospectus supplement | Dec 19, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
Dec 5, 2025 | Dec 5, 2025 |
| 4 | Insider transaction | Nov 24, 2025 | Nov 23, 2025 |
| 4 | Insider transaction | Nov 24, 2025 | Nov 23, 2025 |
| 4 | Insider transaction | Nov 24, 2025 | Nov 23, 2025 |
| 4 | Insider transaction | Nov 24, 2025 | Nov 23, 2025 |
| 4 | Insider transaction | Nov 24, 2025 | Nov 23, 2025 |
| 4 | Insider transaction | Nov 24, 2025 | Nov 23, 2025 |
| 4 | Insider transaction | Nov 24, 2025 | Nov 23, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 13, 2025 | Nov 13, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 13, 2025 | — |
| DEF 14A | Proxy statement | Nov 10, 2025 | Nov 10, 2025 |
| PRE 14A | Preliminary proxy statement | Oct 31, 2025 | Oct 31, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 30, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 30, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 30, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Oct 29, 2025 | Oct 28, 2025 |
| 424B5 | Prospectus supplement | Oct 28, 2025 | — |
| 8-K |
Current report
Material agreement, Agreement ended
|
Oct 20, 2025 | Sep 30, 2025 |
| 424B5 | Prospectus supplement | Oct 20, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 30, 2025 | Sep 30, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Sep 19, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 18, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Sep 18, 2025 | Sep 17, 2025 |
| 424B5 | Prospectus supplement | Sep 18, 2025 | — |
| 424B5 | Prospectus supplement | Sep 16, 2025 | — |
| 4 | Insider transaction | Aug 15, 2025 | Aug 13, 2025 |
| 4 | Insider transaction | Aug 15, 2025 | Aug 13, 2025 |
| 4 | Insider transaction | Aug 15, 2025 | Aug 13, 2025 |
| 4 | Insider transaction | Aug 15, 2025 | Aug 13, 2025 |
| 4 | Insider transaction | Aug 15, 2025 | Aug 13, 2025 |
| 4 | Insider transaction | Aug 15, 2025 | Aug 13, 2025 |
| 4 | Insider transaction | Aug 15, 2025 | Aug 13, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 14, 2025 | Aug 14, 2025 |
| 8-K |
Current report
Other events
|
Jul 11, 2025 | Jul 10, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 29, 2025 | May 28, 2025 |
| 4 | Insider transaction | May 27, 2025 | May 23, 2025 |
| 4 | Insider transaction | May 27, 2025 | May 23, 2025 |
| 4 | Insider transaction | May 27, 2025 | May 23, 2025 |
| 4 | Insider transaction | May 27, 2025 | May 23, 2025 |
| 4 | Insider transaction | May 27, 2025 | May 23, 2025 |
| 4 | Insider transaction | May 27, 2025 | May 23, 2025 |
| 4 | Insider transaction | May 27, 2025 | May 23, 2025 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 28, 2025 | Apr 25, 2025 |
| DEF 14A | Proxy statement | Apr 14, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 27, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 27, 2025 | Mar 27, 2025 |
| 8-K |
Current report
Other events
|
Feb 21, 2025 | Feb 21, 2025 |
| 8-K |
Current report
Listing notice
|
Jan 10, 2025 | Jan 10, 2025 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 23, 2024 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 23, 2024 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 23, 2024 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 23, 2024 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 23, 2024 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 23, 2024 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 25, 2024 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Nov 8, 2024 | Aug 29, 2024 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 7, 2024 | Nov 7, 2024 |
| 424B5 | Prospectus supplement | Oct 18, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Aug 30, 2024 | Aug 29, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 8, 2024 | Aug 8, 2024 |
| DEF 14A | Proxy statement | Jul 16, 2024 | Jul 16, 2024 |
| 8-K |
Current report
Other events
|
Jun 14, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | May 28, 2024 | May 23, 2024 |
| 4 | Insider transaction | May 28, 2024 | May 23, 2024 |
| 4 | Insider transaction | May 28, 2024 | May 23, 2024 |
| 4 | Insider transaction | May 28, 2024 | May 23, 2024 |
| 4 | Insider transaction | May 28, 2024 | May 23, 2024 |
| 4 | Insider transaction | May 28, 2024 | May 23, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 9, 2024 | May 9, 2024 |
| 4 | Insider transaction | Apr 29, 2024 | Apr 26, 2024 |
| 4 | Insider transaction | Apr 29, 2024 | Apr 26, 2024 |
| 4 | Insider transaction | Apr 29, 2024 | Apr 26, 2024 |
| 4 | Insider transaction | Apr 29, 2024 | Apr 26, 2024 |
| 4 | Insider transaction | Apr 29, 2024 | Apr 26, 2024 |
| 4 | Insider transaction | Apr 29, 2024 | Apr 26, 2024 |
| 4 | Insider transaction | Apr 29, 2024 | Apr 26, 2024 |
| 3 | Initial insider ownership | Mar 20, 2024 | Mar 15, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 15, 2024 | Mar 15, 2024 |
| 10-K | Annual report | Mar 14, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 14, 2024 | Mar 14, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| 4 | Insider transaction | Nov 27, 2023 | Nov 23, 2023 |
| 4 | Insider transaction | Nov 27, 2023 | Nov 23, 2023 |
| 4 | Insider transaction | Nov 27, 2023 | Nov 23, 2023 |
| 4 | Insider transaction | Nov 27, 2023 | Nov 23, 2023 |
| 4 | Insider transaction | Nov 27, 2023 | Nov 23, 2023 |
| 4 | Insider transaction | Nov 27, 2023 | Nov 23, 2023 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Aug 31, 2023 | Aug 30, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 10, 2023 | Aug 10, 2023 |
| DEF 14A | Proxy statement | Jul 20, 2023 | Jul 20, 2023 |
| 4 | Insider transaction | Jun 13, 2023 | Jun 12, 2023 |
| 4 | Insider transaction | Jun 13, 2023 | Jun 12, 2023 |
| 4 | Insider transaction | Jun 13, 2023 | Jun 12, 2023 |
| 4 | Insider transaction | Jun 13, 2023 | Jun 12, 2023 |
| 4 | Insider transaction | May 24, 2023 | May 23, 2023 |
| 4 | Insider transaction | May 24, 2023 | May 23, 2023 |
| 4 | Insider transaction | May 24, 2023 | May 23, 2023 |
| 4 | Insider transaction | May 24, 2023 | May 23, 2023 |
| 4 | Insider transaction | May 24, 2023 | May 23, 2023 |
| 4 | Insider transaction | May 24, 2023 | May 23, 2023 |
| 8-K |
Current report
Officer or director change
|
May 16, 2023 | May 12, 2023 |
| 4 | Insider transaction | May 15, 2023 | May 15, 2023 |
| 4 | Insider transaction | May 15, 2023 | May 15, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 11, 2023 | May 11, 2023 |
| EFFECT | Filing | Apr 6, 2023 | — |
| 8-K |
Current report
Auditor change
|
Apr 5, 2023 | Mar 31, 2023 |
| CORRESP | Letter to the SEC | Apr 4, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 22, 2023 | — |
| 4 | Insider transaction | Mar 21, 2023 | Mar 20, 2023 |
| S-3 | Shelf registration | Mar 16, 2023 | — |
| 10-K | Annual report | Mar 16, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 16, 2023 | Mar 16, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2023 | — |
| S-8 | Employee stock plan registration | Jan 23, 2023 | — |
| 4 | Insider transaction | Jan 19, 2023 | Jan 17, 2023 |
| 4 | Insider transaction | Jan 19, 2023 | Jan 17, 2023 |
| 4 | Insider transaction | Jan 19, 2023 | Jan 17, 2023 |
| 4 | Insider transaction | Jan 19, 2023 | Jan 17, 2023 |
| 4 | Insider transaction | Jan 19, 2023 | Jan 17, 2023 |
| 4 | Insider transaction | Jan 19, 2023 | Jan 17, 2023 |
| 4 | Insider transaction | Jan 9, 2023 | Jan 8, 2023 |
| 4 | Insider transaction | Jan 9, 2023 | Jan 8, 2023 |
| 4 | Insider transaction | Jan 9, 2023 | Jan 8, 2023 |
| 4 | Insider transaction | Jan 9, 2023 | Jan 8, 2023 |
| 4 | Insider transaction | Nov 23, 2022 | Nov 23, 2022 |
| 4 | Insider transaction | Nov 23, 2022 | Nov 23, 2022 |
| 4 | Insider transaction | Nov 23, 2022 | Nov 23, 2022 |
| 4 | Insider transaction | Nov 23, 2022 | Nov 23, 2022 |
| 4 | Insider transaction | Nov 23, 2022 | Nov 23, 2022 |
| 4 | Insider transaction | Nov 23, 2022 | Nov 23, 2022 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Sep 2, 2022 | Aug 31, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- CODX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- UT
- Headquarters
- Salt Lake City, UT
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1692415
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.